Purchase Order N0017314P0528
- Not listed
- The Office of Naval Research (ONR) awarded a $4,410 firm fixed-price purchase order to Bio-Synthesis, Inc. on February 24, 2016, for biologicals, with performance completion targeted for March 23, 2016. Bio-Synthesis, Inc., a Hispanic American-owned manufacturer based in Lewisville, Texas, and operating under the trade name Dnaexam, specializes in custom synthesis of advanced biological research materials including peptides, RNA, and nucleic acid products. No set-aside designation was applied to...
- The Office of Naval Research awarded a firm fixed-price purchase order valued at $13,220 to Bio-Synthesis, Inc. (doing business as Dnaexam) on February 6, 2017, with an ultimate completion date of March 8, 2017. The contract, registered under PR# 69-4143-17, was issued without a set-aside designation and covers biologicals to be delivered to Lewisville, Texas. Bio-Synthesis, Inc., a Hispanic American-owned manufacturer of specialized biological research materials headquartered in Lewisville,...
- The Office of Naval Research awarded a $4,375 purchase order to Bio-Synthesis, Inc. for custom CECA peptide synthesis services. The contract, issued on May 29, 2014, with an ultimate completion date of June 23, 2014, represents a firm fixed-price engagement with no set-aside designation. Bio-Synthesis, Inc., a Hispanic American-owned manufacturer based in Lewisville, Texas, and operating under the trade name Dnaexam, specializes in advanced biological research materials and custom molecular...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Bio-Synthesis, Inc. for chemical RNA ubermers and RNA transcription synthesis, valued at $5,210.00, with an award date of March 21, 2018 and completion date of March 20, 2019. Work is performed in Lewisville, Texas. Bio-Synthesis, Inc. is a Hispanic American-owned manufacturer of biological research materials.</p>
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Bio-Synthesis, Inc., a Hispanic American-owned small business. The contract is for custom peptide synthesis services, with a ceiling value of $3,259.00 and an ultimate completion date of February 25, 2015. The contract was awarded on February 18, 2015 and did not use a set-aside....
- The Office of Naval Research (ONR) awarded a $3,830.85 firm fixed price purchase order to Genscript USA Inc. on June 17, 2016, for protein services with an ultimate completion date of July 21, 2016. The contract, which was not set aside for small businesses, will be performed at the contractor's facility in Piscataway, New Jersey. Genscript USA Inc., a biotechnology company specializing in advanced molecular biology services, was selected to provide these protein-related services in support of...
- The U.S. Office of Naval Research (ONR) awarded a $8,995.00 firm fixed-price purchase order to Biolytic Lab Performance Inc., a veteran-owned for-profit organization, for the repair of equipment. The contract has a completion date of September 9, 2024 and was not set aside for any specific business type. Biolytic Lab Performance Inc. is a provider of DNA synthesis solutions, including oligonucleotide synthesizers, chemistry instruments, and laboratory equipment, to various federal agencies...
- <p>The Office of Naval Research issued a purchase order to Genscript USA Inc. valued at $4,444.42 on April 6, 2017, for peptide synthesis services. Work is performed in Piscataway, New Jersey, with an ultimate completion date of May 31, 2017. The order is firm fixed price with no small business set-aside.</p>
- This is a $10,585.00 firm fixed price purchase order awarded by the National Heart Lung and Blood Institute, a civilian agency, to Bio-Synthesis, Inc., a Hispanic American-owned manufacturer of goods. The contract is for the delivery of stapled NIX-derived peptides with derivatized N-termini to support the agency's ongoing study of the NIX/WIPI protein interaction, which began in March 2023. The award does not utilize a set-aside designation, and the ultimate completion date is June 24, 2025.
- This federal contract award, with the ID HHSN272201200589P, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Bio-Synthesis, Inc. (doing business as Dnaexam), a for-profit, Hispanic American-owned manufacturer. The contract, with a firm fixed price of $5,565.00, is for the delivery of drugs and biologicals. The contract does not have a set-aside designation and was awarded on July 18, 2012, with a...
The Office of Naval Research (ONR) awarded a $3,400 purchase order to Bio-Synthesis, Inc., a Hispanic American-owned manufacturer specializing in custom peptide synthesis and advanced biological research materials. The firm fixed price contract, issued on January 15, 2014, with an ultimate completion date of February 5, 2014, was performed at Bio-Synthesis's facility in Lewisville, Texas. No set-aside designation was utilized for this award. Bio-Synthesis, Inc., which operates under the trade name Dnaexam, has established itself as a capable supplier of specialized molecular and genetic research products for federal research institutions since its registration in the System for Award Management in 2002. This contract supports ONR's research objectives through the delivery of custom peptide materials, consistent with Bio-Synthesis's demonstrated expertise in producing complex biological synthesis products for defense and civilian research applications. The company's track record includes previous federal awards from health-related research agencies such as the National Heart Lung and Blood Institute and National Institute of Allergy and Infectious Diseases, reflecting its technical capacity to deliver high-quality, precision molecular research materials that meet rigorous federal specifications and timelines.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 1/14/14 |